App-Quantinova.ai

SARILUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: RESULTS OF A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY

T.W. Huizinga - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute lung injury

Methotrexate

OSTEOPOROSIS IN CALCIUM PYROPHOSPHATE DEPOSITION DISEASE

F. Kudaeva - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Parathyroid hormone

ANALYSIS OF SURVIVAL AND CAUSES OF DEATH OF PATIENTS WITH GOUT

M.S. Eliseev - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic kidney disease

N/A

CLINICAL AND ULTRASOUND EXAMINATOIN OF ENTHESIS IN EARLY PSORIATIC ARTHRITIS

I. Troshkina - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

N/A

EFFECT OF LOW DOSE ORAL PREDNISOLONE ON SYMPTOMS AND SYSTEMIC INFLAMMATION IN OLDER ADULTS WITH MODERATE TO SEVERE KNEE OSTEOARTHRITIS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL

A. Abou-Raya - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Systemic inflammation

Glucocorticoid

IDENTIFICATION OF SEROLOGICAL BIOMARKER PROFILES ASSOCIATED WITH EARLY RESPONSE TO TOCILIZUMAB IN RHEUMATOID ARTHRITIS

A.C. Bay-Jensen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Rheumatoid arthritis

Tocilizumab

PREVALENCE OF VITAMIN D DEFICIENCY IN RHEUMATOID ARTHRITIS PATIENTS: ASSOCIATION WITH ANAEMIA OF INFLAMMATION AND EFFECT OF VITAMIN D SUPPLEMENTATION

A. Abou-Raya - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anemia

cholecalciferol

FATIGUE IN RHEUMATOID ARTHRITIS PATIENTS: THE IMPACT OF DISEASE ACTIVITY, PAIN, DISABILITY AND DEPRESSIVE DISORDERS

T.A. Lisitsyna - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

Prednisone

CARDIAC ABNORMALITIES AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH RHEUMATOID ARTHRITIS

D. Abdel Mohsen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Left ventricular diastolic dysfunction

Angiotensin II

NNC0109-0012 (ANTI-IL-20 MAB), WELL TOLERATED IN PATIENTS WITH RHEUMATOID ARTHRITIS

P. Leszczynski - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Acetaminophen

MRI FINDINGS ARE PREVALENT IN ACPA POSITIVE PATIENTS WITH MUSCULOSKELETAL SYMPTOMS

J.L. Nam - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

IS THERE AN-IDEA- SCORE FOR CARDIO-VASCULAR RISK EVALUATION ON LUPUS PATIENTS?

C.M. Ancuta - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

N/A

STRUCTURAL PROGRESSION OF ANKYLOSING SPONDYLITIS ASSOCIATED WITH ELEVATION IN TWO NOVEL, INFLAMMATORY BIOMARKERS; MATRIX METALLOPROTEINASE AND CATHEPSIN-DERIVED CRP

A.C. Bay-Jensen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

CORRELATION BIOMARKERS OF CARTILAGE AND BONE TURNOVER WITH DISEASE ACTIVITY, ASDAS, FUNCTION, QUALITY OF LIFE, RADIOLOGY AND MAGNETIC RESONANCE IMAGING IN PATIENTS WITH EARLY SPONDILOARTHRITIS

R. Almodovar - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Inflammatory bowel disease

N/A

TWO NOVEL DIAGNOSTIC BIOMARKERS OF CARTILAGE DEGRADATION AND CONNECTIVE TISSUE INFLAMMATION ARE PREDICTIVE OF DISEASE PROGRESSION IN ANKYLOSING SPONDYLITIS

A.C. Bay-Jensen - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Methotrexate

SERUM BIOMARKERS TO PREDICT CLINICAL RESPONSE IN PROOF-OF-CONCEPT TRIALS IN SPONDYLOARTHRITIS

M. Turina - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

ILS-969

CORRELATION BETWEEN COLCHICINE EFFECTS ON EARLY ATRIAL FIBRILLATION RECURRENCE AFTER ABLATION AND LEFT ATRIUM EPICARDIAL ADIPOSE TISSUE VOLUME

Yasuyuki Egami - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Colchicine

BIOMARKER PREDICTORS OF CARDIAC HOSPITALIZATION IN CHRONIC HEART FAILURE: A RECURRENT EVENT ANALYSIS

Esther E. Vorovich - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

L-Tyrosine

ASSOCIATION BETWEEN CARDIAC, INFLAMMATORY, RENAL, AND HEPATIC BIOMARKERS AND OUTCOMES IN PATIENTS WITH A HEART FAILURE HOSPITALIZATION

Katherine Waltman Johnson - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

C-REACTIVE PROTEIN DOES NOT PREDICT THERAPEUTIC RESPONSE IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS

Wen-Hsin Jiang - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

N/A

Filters

1408 Abstracts